Savolitinib ± Osimertinib in Japanese Patients with Advanced Solid Malignancies or EGFRm NSCLC: Ph1b TATTON Part C
メタデータ
- 公開日
- 2021-01-01
- DOI
-
- 10.6084/m9.figshare.14139947
- 10.6084/m9.figshare.14139947.v1
- 公開者
- Adis Journals
- データ作成者 (e-Rad)
-
- Kiyotaka Yoh (501304)
- Tomonori Hirashima (493159)
- Hideo Sakai (7966385)
- Takayasu Kurata (411761)
- Yuichiro Ohe (213191)
- Toyoaki Hida (2940405)
- Anders Mellemgaard (3643525)
- Remy B Verheijen (10217118)
- Xiaoling Ou (10217119)
- Ghada F. Ahmed (10217121)
- Manabu Hayama (10217122)
- Ko Sugibayashi (10217124)
- Geoffrey R. Oxnard (5202074)
説明
Full text:https://link.springer.com/article/10.1007/s11523-021-00806-5<br> <br> The above Plain Language Summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.
